Measurement of
cardiac troponin I in serum with a new high-sensitivity assay in a large multi-ethnic Asian cohort and the impact of gender.
Matrix and bilirubin interference for high-sensitivity
cardiac troponin I. Clin Chim Acta 2015; 442:49-51.
High sensitivity
cardiac troponin I and T assays for predicting death in a hemodialysis population.
Cardiac troponin is the standard biomarker for detection of myocardial injury.
Normal plasma levels of
cardiac troponin I measured by the high-sensitivity
cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia.
Role of monitoring changes in sensitive
cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events.
Comparison of myoglobin, creatine kinase-MB, and
cardiac troponin I for diagnosis of acute myocardial infarction.
The complete pharmacokinetic profile of serum
cardiac troponin I in the rat and the dog.
Cardiac troponin is a member of a complex group of proteins that modulate the calcium-mediated interaction between actin and myosin within the cardiac myocytes.
[2] Nonstandard abbreviations: cTnT, cardiac troponin T; cTnI,
cardiac troponin I; AMI, acute myocardial infarction; ACS, acute coronary syndromes; TnC, troponin C; HAMA, human antimouse antibodies.
Indeed, proteolysis will produce various
cardiac troponin I molecules with varying degrees of stability hence it is not unreasonable to assume that unpredictable interactions between these molecules and the antibodies in the assay can occur [12].
Anecdotal experience in the laboratory was that clinicians were continuing to order
cardiac troponin I (cTnI) together with the CK-MB isoform in cases of suspected ACS.